13F Filings History of Birchview Capital, LP
- Latest 13F filing
- Q1 2026 - 15 May 2026
- Latest reported 13F value
- $175,663,720
- Largest 13F holdings
-
KLAC BMY CMPX LRCX STOK OVV NTLA GPCR SLDB PRTA BDSX ACAD
+8 more
PTGX NBIX OLMA RLMD OCUL UTHR NKTR CLDX - Form 13F summary
-
- Birchview Capital, LP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Birchview Capital, LP reported 73 equity holdings with a total reported market value of $175,663,720 for Q1 2026. Top reported holdings included KLAC, BMY, CMPX, LRCX, and STOK.
- Manager signature
- John Trottier - CFO/CCO
- Manager location
- Burlington, VT
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Birchview Capital, LP with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q1 2026
Latest value
$175,663,720
Quarter delta
+$4,865,160
Accepted
15 May 2026, 14:51
Rows shown
1-25 of 52
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 73 | $175,663,720 | +$24,749,821 | -$26,324,932 | -$1,575,111 | KLAC, BMY, CMPX, LRCX, STOK | 13F-HR | 15 May 2026, 14:51 |
| Q4 2025 | 68 | $170,798,560 | +$36,470,603 | -$15,053,172 | +$21,417,431 | KLAC, BMY, CMPX, STOK, LRCX | 13F-HR | 13 Feb 2026, 10:19 |
| Q3 2025 | 69 | $132,446,155 | +$21,995,216 | -$50,370,058 | -$28,374,842 | KLAC, BMY, CORT, PRTA, STOK | 13F-HR | 13 Nov 2025, 15:30 |
| Q2 2025 | 71 | $100,695,689 | +$25,150,660 | -$22,741,770 | +$2,408,890 | BMY, KLAC, CORT, OVV, ACAD | 13F-HR | 14 Aug 2025, 13:43 |
| Q1 2025 | 68 | $115,021,460 | +$4,136,001 | -$10,955,099 | -$6,819,098 | BMY, CORT, ACAD, PRTA, BDSX | 13F-HR | 15 May 2025, 16:48 |
| Q4 2024 | 68 | $122,779,849 | $0 | $0 | $0 | BMY, BDSX, ACAD, ELUT, PRTA | New Holdings | 30 Jun 2025, 11:19 |
| Q4 2024 | 68 | $122,779,849 | +$8,257,134 | -$3,971,378 | +$4,285,756 | BMY, BDSX, ACAD, ELUT, PRTA | 13F-HR | 14 Feb 2025, 13:56 |
| Q3 2024 | 61 | $115,489,427 | $0 | $0 | $0 | BMY, BDSX, ACAD, ELUT, UTHR | New Holdings | 30 Jun 2025, 11:13 |
| Q3 2024 | 61 | $115,489,427 | +$7,205,980 | -$13,593,718 | -$6,387,738 | BMY, BDSX, ACAD, ELUT, UTHR | 13F-HR | 14 Nov 2024, 14:42 |
| Q2 2024 | 60 | $108,192,580 | $0 | $0 | $0 | BMY, BDSX, ELUT, NBIX, SILK ROAD MEDICAL INC | New Holdings | 30 Jun 2025, 11:09 |
| Q2 2024 | 60 | $108,192,580 | +$4,050,884 | -$9,716,805 | -$5,665,921 | BMY, BDSX, ELUT, NBIX, SILK | 13F-HR | 13 Aug 2024, 16:11 |
| Q1 2024 | 59 | $122,695,509 | $0 | $0 | $0 | BMY, NBIX, BDSX, ELUT, ACAD | New Holdings | 30 Jun 2025, 11:03 |
| Q1 2024 | 59 | $122,695,509 | +$2,508,417 | -$6,773,350 | -$4,264,933 | BMY, NBIX, BDSX, ELUT, ACAD | 13F-HR | 14 May 2024, 15:26 |
| Q4 2023 | 58 | $127,809,273 | $0 | $0 | $0 | BMY, NBIX, BDSX, ACAD, PRTA | New Holdings | 30 Jun 2025, 10:46 |
| Q4 2023 | 58 | $127,809,273 | +$6,847,387 | -$2,260,923 | +$4,586,464 | BMY, NBIX, BDSX, ACAD, PRTA | 13F-HR | 13 Feb 2024, 17:58 |
| Q3 2023 | 51 | $117,708,654 | $0 | $0 | $0 | BMY, BDSX, NBIX, PRTA, ACAD | New Holdings | 30 Jun 2025, 10:34 |
| Q3 2023 | 51 | $117,708,654 | +$4,734,865 | -$16,859,236 | -$12,124,371 | BMY, BDSX, NBIX, PRTA, ACAD | 13F-HR | 14 Nov 2023, 15:49 |
| Q2 2023 | 54 | $133,413,992 | +$4,834,134 | -$766,169 | +$4,067,965 | BMY, PRTA, NBIX, BDSX, ACAD | 13F-HR | 08 Aug 2023, 12:23 |
| Q1 2023 | 55 | $127,725,000 | +$2,104,899 | -$4,406,000 | -$2,301,101 | BMY, BDSX, NBIX, PRTA, QDEL | 13F-HR | 12 May 2023, 10:18 |
| Q4 2022 | 57 | $141,566,000 | +$9,381,759 | -$6,772,174 | +$2,609,585 | BMY, BDSX, NBIX, PRTA, ELUT | 13F-HR | 03 Feb 2023, 12:28 |
| Q3 2022 | 60 | $142,011,000 | +$2,742,669 | -$7,030,251 | -$4,287,582 | BMY, ELUT, NBIX, PRTA, QDEL | Restatement | 28 Nov 2022, 13:44 |
| Q2 2022 | 60 | $137,477,000 | +$9,779,625 | -$7,135,889 | +$2,643,736 | BMY, ELUT, NBIX, QDEL, FHTX | 13F-HR | 12 Aug 2022, 08:04 |
| Q1 2022 | 63 | $138,903,000 | +$3,429,891 | -$5,215,653 | -$1,785,762 | BMY, NBIX, ELUT, QDEL, ACAD | 13F-HR | 13 May 2022, 09:54 |
| Q4 2021 | 67 | $155,071,000 | +$15,092,907 | -$4,846,350 | +$10,246,557 | BMY, AXDX, ELUT, QDEL, NBIX | 13F-HR | 14 Feb 2022, 11:43 |
| Q3 2021 | 64 | $146,958,000 | +$4,072,529 | -$2,844,661 | +$1,227,868 | BMY, AXDX, BDSX, QDEL, NBIX | 13F-HR | 12 Nov 2021, 08:43 |